ro-09-1437 and coumermycin

ro-09-1437 has been researched along with coumermycin* in 1 studies

Other Studies

1 other study(ies) available for ro-09-1437 and coumermycin

Article	Year
GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4 The sequence of the gyrase B subunit gene from Staphylococcus aureus strains resistant to the gyrase B subunit inhibitors cyclothialidine, coumermycin, and novobiocin has been determined. The residues altered in the resistant gyrase B subunits map to the ATP-binding region, suggesting that the drugs inhibit ATP binding and hydrolysis. The pattern of cross-resistances indicates that the detailed binding mode of the compounds differs. Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; DNA Gyrase; DNA Topoisomerases, Type II; Microbial Sensitivity Tests; Mutation; Novobiocin; Peptides, Cyclic; Sequence Homology, Nucleic Acid; Staphylococcus aureus	1996

Article

Year

GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.

Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4

The sequence of the gyrase B subunit gene from Staphylococcus aureus strains resistant to the gyrase B subunit inhibitors cyclothialidine, coumermycin, and novobiocin has been determined. The residues altered in the resistant gyrase B subunits map to the ATP-binding region, suggesting that the drugs inhibit ATP binding and hydrolysis. The pattern of cross-resistances indicates that the detailed binding mode of the compounds differs.

Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; DNA Gyrase; DNA Topoisomerases, Type II; Microbial Sensitivity Tests; Mutation; Novobiocin; Peptides, Cyclic; Sequence Homology, Nucleic Acid; Staphylococcus aureus

1996